# The Effect of GLP-1 on the Inhibition of Glucagon Secretion

> **NCT01507597** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 30 (actual)

## Conditions studied

- Type 2 Diabetes
- Type 1 Diabetes

## Interventions

- **DRUG:** Native human Glucagon-like Peptide-1 ( GLP-1(7-36))
- **DRUG:** NaCl
- **DRUG:** Native human Glucagon-like Peptide-1 ( GLP-1(7-36))
- **DRUG:** Native human Glucagon-like Peptide-1 ( GLP-1(7-36))

## Key facts

- **NCT ID:** NCT01507597
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01507597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01507597, "The Effect of GLP-1 on the Inhibition of Glucagon Secretion". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01507597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*